GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda) cause weight loss by suppressing appetite, increasing feelings of fullness, and slowing gastric emptying, which leads to reduced caloric intake rather than increased calorie burning
Detailed stages of the cycle: CPT-1 (outer mitochondrial membrane): Acyl-CoA + L-carnitine Acyl-carnitine + CoA-SH Rate limiting enzyme Inhibited by malonyl-CoA Isoforms: CPT-1A (liver), CPT-1B (muscle), CPT-1C (brain) CACT (translocase): Transport of acylcarnitine into the matrix Antiport with free carnitine The only transporter for acylcarnitines CPT-2 (inner mitochondrial membrane): Acyl-carnitine + CoA-SH Acyl-CoA + L-carnitine Regeneration of acyl-CoA in the matrix Not regulated by malonyl-CoA -oxidation (matrix): Cyclic shortening of the acyl chain Products: acetyl-CoA, FADH2, NADH CPT-1 regulation Research on Cell Cultures L-carnitine tested on various cell types: Cardiomyocytes: main source of energy from -oxidation Myotubes (C2C12): skeletal muscle metabolism Hepatocytes: ketogenesis and gluconeogenesis Adipocytes: lipolysis and lipid metabolism Cancer cells: Warburg metabolism vs
1 February 2023
Its also important to consider that the population typically using semaglutide, such as those with type 2 diabetes or obesity, may already be at a higher risk for thyroid disorders
SLIDESHOW See Slideshow What are the side effects of Ozempic
DHEA Suppositories are inserted vaginally and are designed to support vaginal health and comfort
